Literature DB >> 9551488

The new epidemiology of schizophrenia.

P Jones1, M Cannon.   

Abstract

A confluence of findings from different vantage points has led to renewed interest and direction in the epidemiology of schizophrenia. This article provides an overview of prevalence and incidence data, examining the validity of reported secular trends in the occurrence of schizophrenia. Advances in molecular genetics have uncovered new linkage on chromosomes 6, 8, and 22 and have suggested complex models, including anticipation, to explain the perpetuation of genetic transmission in the face of low fecundity. Neurotropic viruses and autoimmunity have emerged as pathoplastic mechanisms to explain recent intriguing epidemiologic associations in schizophrenia. Environmental risk factors are also important. With attention to particular risk factors (i.e., perinatal hypoxia), a preventative approach may be realistic for some forms of schizophrenia.

Entities:  

Mesh:

Year:  1998        PMID: 9551488     DOI: 10.1016/s0193-953x(05)70358-0

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  13 in total

1.  Gene-environment interactions in mental disorders.

Authors:  Ming T Tsuang; Jessica L Bar; William S Stone; Stephen V Faraone
Journal:  World Psychiatry       Date:  2004-06       Impact factor: 49.548

2.  A qualitative research study of the evolution of symptoms in individuals identified as prodromal to psychosis.

Authors:  Cheryl Corcoran; Larry Davidson; Rachel Sills-Shahar; Connie Nickou; Dolores Malaspina; Tandy Miller; Thomas McGlashan
Journal:  Psychiatr Q       Date:  2003

Review 3.  Olanzapine. A pharmacoeconomic review of its use in schizophrenia.

Authors:  R H Foster; K L Goa
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

4.  Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

Authors:  Boris Sakic; David L Kirkham; David A Ballok; James Mwanjewe; Ian M Fearon; Joseph Macri; Guanhua Yu; Michelle M Sidor; Judah A Denburg; Henry Szechtman; Jonathan Lau; Alexander K Ball; Laurie C Doering
Journal:  J Neuroimmunol       Date:  2005-09-29       Impact factor: 3.478

Review 5.  What risk factors tell us about the causes of schizophrenia and related psychoses.

Authors:  J Kelly; R M Murray
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

6.  Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia.

Authors:  Xinzhi Zhao; Ruqi Tang; Bo Gao; Yongyong Shi; Jian Zhou; Shengzhen Guo; Jing Zhang; Yabing Wang; Wei Tang; Junwei Meng; Sheng Li; Hongsheng Wang; Gang Ma; Chuwen Lin; Yue Xiao; Guoyin Feng; Zhiguang Lin; Shaomin Zhu; Yangling Xing; Hong Sang; David St Clair; Lin He
Journal:  Am J Hum Genet       Date:  2006-11-13       Impact factor: 11.025

7.  Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study.

Authors:  C M Hultman; P Sparén; N Takei; R M Murray; S Cnattingius
Journal:  BMJ       Date:  1999-02-13

Review 8.  Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.

Authors:  Michael A Cirillo; Larry J Seidman
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

9.  Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings.

Authors:  Robyn A Honea; Andreas Meyer-Lindenberg; Katherine B Hobbs; Lukas Pezawas; Venkata S Mattay; Michael F Egan; Beth Verchinski; Richard E Passingham; Daniel R Weinberger; Joseph H Callicott
Journal:  Biol Psychiatry       Date:  2007-08-08       Impact factor: 13.382

Review 10.  Dimensions and the psychosis phenotype.

Authors:  Judith Allardyce; Trisha Suppes; Jim Van Os
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.